https://www.openbell.ai/ 2026-09-26T20:55:22.123Z hourly 1.0 https://www.openbell.ai/support 2026-09-26T20:55:22.123Z monthly 0.7 https://www.openbell.ai/privacy 2026-09-26T20:55:22.123Z monthly 0.5 https://www.openbell.ai/terms 2026-09-26T20:55:22.123Z monthly 0.5 https://www.openbell.ai/feed.json 2026-09-26T20:55:22.123Z hourly 0.8 https://www.openbell.ai/news/MU:1790451916419 2026-09-26T19:45:16.419Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/26/The-Micron-Logo-Appears---EK.jpg?width=250&height=187 Micron Stock Clears Key Resistance as Analysts Predict 352% Revenue Surge Micron Technology (NASDAQ: MU) stock has surged past the key resistance level of $1,040, recovering from a low of $737. Analysts predict a significant revenue increase, with estimates suggesting fourth-quarter revenue could reach $51.24 billion, a 352% rise from the previous year, and annual revenue could hit $130 billion. The company anticipates earnings-per-share to rise to $31.6, up from $3 last year, and expects gross margins to exceed 84%. Micron's stock forecast among analysts averages $1,336. https://www.openbell.ai/news/CRCL:1790448365834 2026-09-26T18:46:05.834Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/26/Denver--Colorado---June-18-2025-Circle-C.jpg?width=250&height=187 Circle Stock Eyes Comeback Past $100 as Arc L1, USDC, and Bond Yields Jump Circle (NYSE: CRCL) stock has decreased by 14% from its monthly high, despite improvements in its fundamentals, including the launch of its Arc Layer 1 network, which has a total value locked (TVL) nearing $500 million. The USDC supply has surpassed $75 billion, contributing to a market capitalization of over $484 million for Arc, while US bond yields have risen to 4.14%, which is expected to increase Circle's revenue. The stock is currently priced at $89, with potential for a rebound to $125 if it surpasses the resistance level of $102.6. https://www.openbell.ai/news/XRP:1790444707115 2026-09-26T17:45:07.115Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/26/Digital-Art-Xrp-Logo-Symbol--Ripple-Cryp.jpg?width=250&height=187 XRP Price Shows Calm Before the Storm as ETFs Near $2 Billion Milestone XRP is currently trading at $1.5485, underperforming compared to other altcoins, but is experiencing significant ETF inflows, with cumulative assets nearing $1.8 billion and expected to cross the $2 billion milestone soon. The Bitwise XRP ETF leads with $647 million in assets, while XRP's futures open interest has reached $3.6 billion, indicating rising demand. Additionally, XRP is on the verge of forming a golden cross pattern, which may signal a bullish breakout towards the $2 mark. https://www.openbell.ai/news/BTC:1790440206500 2026-09-26T16:30:06.500Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/26/Bitcoin.jpg?width=250&height=187 Bitcoin Price Eyes Rally to $100,000 as ETF Inflows Surge, Technicals Align Bitcoin (BTC) reached a multi-month high of $87,270 before retreating to below $84,000 amid rising US bond yields. ETF inflows surged, with spot Bitcoin ETFs adding $2.4 billion for the week and $2.7 billion for the month, indicating positive investor sentiment. Additionally, Bitcoin treasury companies are accumulating, with notable purchases from Michael Saylor's Strategy and Strive. Technical indicators suggest a potential rise to $100,000, supported by bullish chart patterns. https://www.openbell.ai/news/NKE:1790436666432 2026-09-26T15:31:06.432Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/26/Nike-Mind-Shoes-Sell-Out-On-Brain-Boosti.jpg?width=250&height=187 Nike Stock Has Become Oversold. Will Upcoming Earnings Lead to a Reversal? Nike's stock (NYSE: NKE) has fallen 78.2% from its November 2021 high, reaching its lowest level since October 2014. Analysts estimate a 3.38% decline in quarterly revenue to $11.32 billion and a drop in earnings-per-share to 44 cents, down from 49 cents a year prior. The company is implementing a turnaround strategy under Elliot Hill, focusing on cost cuts and improving wholesaler relationships, with investors keenly awaiting the upcoming earnings report for signs of recovery. https://www.openbell.ai/news/XRPUSD:1790433017062 2026-09-26T14:30:17.062Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/26/Xrp-Logo-And-Coins-With-Focal-Length-Eff.jpg?width=250&height=187 XRP Could Overtake Bitcoin, Analyst Says: 'Life Happens Fast' Analyst Rob Cunningham suggests that XRP could potentially overtake Bitcoin if $10 trillion migrates onto the XRP Ledger and a significant portion converts into XRP. He highlights a historical instance where a $66 million inflow led to a $45 billion increase in XRP's valuation, indicating a potential multiplier effect. However, he emphasizes that this scenario relies on several uncertain factors, including the duration capital remains in XRP and the liquidity available as prices rise. Ripple's CTO Emeritus David Schwartz previously noted that XRP's growth would need to outpace Bitcoin in a scenario of overall market expansion. https://www.openbell.ai/news/BTCUSD:1790431240019 2026-09-26T14:00:40.019Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/26/Us-Federal-Reserve-System-Fed-Interest-R.jpg?width=250&height=187 Why Bitcoin Hit $86,000 Despite Fed Rate Hikes - VanEck's Sigel, Former CFTC Chair Weigh In Bitcoin (BTC) surged from approximately $58,000 to a peak of $86,000 despite Fed rate hikes and rising Treasury yields. Analysts Matthew Sigel from VanEck and former CFTC Chair Chris Giancarlo attributed this rally to seller exhaustion and Bitcoin's appeal as a hedge against government debt and currency debasement. Sigel noted that Bitcoin has shown little correlation with bond yields and highlighted its recovery as consistent with its historical four-year cycle. Additionally, Bitcoin's price reclaimed a key technical level above its 50-week moving average, suggesting a positive outlook. https://www.openbell.ai/news/ARM:1790409064078 2026-09-26T07:51:04.078Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/26/West-Bangal--India---July-5--2024-Sk-Hyn.jpg?width=250&height=187 SK Hynix's Solidigm Eyes 2027 IPO at up to $150 Billion Valuation, in Potential Record-Breaking US Chip Listing: Report SK Hynix's U.S. subsidiary Solidigm is reportedly planning an initial public offering (IPO) as early as next year, potentially valuing the company at up to $150 billion. The IPO could raise approximately $15 billion, making it the largest U.S. semiconductor listing on record, although details remain uncertain. Solidigm, which produces enterprise SSDs for AI-powered storage, was created in 2021 after SK Hynix acquired Intel's NAND business for about $9 billion. https://www.openbell.ai/news/LITE:1790401959758 2026-09-26T05:52:39.758Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/26/Fiber-Optic-Cables-Connected-To-An-Optic.jpg?width=250&height=187 Bipartisan Lawmakers Seek to Bar a Chinese AI Data Center Component From Sensitive US Government Systems: ‘We Shouldn’t Rely on China’ Bipartisan lawmakers, including Sens. John Cornyn and Dave McCormick, have introduced legislation to prevent the federal government from using optical transceivers made by Chinese companies Eoptolink and Zhongji Innolight in sensitive systems, citing national security concerns. The proposed restrictions would allow the Commerce and Defense secretaries to add more companies to the list, with a compliance deadline of five years. The technology industry has expressed concerns that such restrictions could disrupt U.S. data center expansion and hinder American competitiveness in AI, as domestic suppliers like Coherent Corp. and Lumentum Holdings currently lack the scale to fully replace Chinese suppliers. https://www.openbell.ai/news/BOND:1790382648769 2026-09-26T00:30:48.769Z daily 0.9 https://cdn.brandfetch.io/BOND/w/400/h/400?c=1idopYfmtR7ZKg8QMud Social Media Discussion: $BOND Main sentiment: Neutral Key theme/event: Concerns over the bond market's warning signals contrasted with a lack of stock market volatility, largely driven by AI focus. https://www.openbell.ai/news/BTLN:1790380200706 2026-09-25T23:50:00.706Z daily 0.9 https://cdn.brandfetch.io/BTLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending openbell Financial News https://www.openbell.ai/news/ABBV:1790373895484 2026-09-25T22:04:55.484Z daily 0.9 https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud U.S. FDA Approves Juvmo (Tavapadon) For Parkinson’s Disease In Adults On Sept 25, 2026 On September 25, 2026, the U.S. FDA approved Juvmo (Tavapadon) for the treatment of Parkinson's disease in adults. This approval is a significant milestone for AbbVie (ABBV), potentially impacting its market position in the neurological treatment sector. The approval may lead to increased revenue opportunities for the company as it expands its product offerings. https://www.openbell.ai/news/SLND:1790372370194 2026-09-25T21:39:30.194Z daily 0.9 https://cdn.brandfetch.io/SLND/w/400/h/400?c=1idopYfmtR7ZKg8QMud Southland Holdings Receives NYSE American Non-Compliance Notice On September 23, 2026, Southland Holdings, Inc. (NYSE: SLND) received a non-compliance notice from NYSE American due to a stockholders’ deficit of $248.2 million and reported net losses in its last three fiscal years, violating listing standards. The company must submit a plan by October 23, 2026, to regain compliance by March 23, 2028, or face potential delisting. Despite the notice, the company's shares will continue to be traded on the NYSE American during this period. https://www.openbell.ai/news/AKAN:1790372140556 2026-09-25T21:35:40.556Z daily 0.9 https://cdn.brandfetch.io/AKAN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Akanda Determined That It Was No Longer Going To Pursue The Cultivation Of Cannabis Or Any Future Cannabis-Related Businesses; Going To Focus Its Business Efforts On Growth, Management Of Its First Towers & Fibers Corp. Subsidiary, Potentially Other Business Targets; Declined To Pay Next Option Payment Due Under Its Amended And Restated Option To Purchase Agreement With 1107385 B.C. LTD; Company’s Right To Acquire Or Use The BC Property Under The Option Agreement Has Been Terminated On September 24, 2026, Akanda Corp. announced it will cease all cannabis cultivation and related business activities, shifting its focus to managing its First Towers & Fibers Corp. subsidiary and exploring other business opportunities. The company declined to make the next payment under its Option Agreement with 1107385 B.C. LTD., resulting in the termination of its right to acquire a THC and CBD farming facility in British Columbia. Akanda has not cultivated any products from this property. https://www.openbell.ai/news/LLY:1790370834308 2026-09-25T21:13:54.308Z daily 0.9 https://cdn.brandfetch.io/LLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Eli Lilly Receives FDA Approval For Olumiant In Pediatric Patients Aged 12 And Older With Severe Alopecia Areata Eli Lilly and Company has received FDA approval for Olumiant (baricitinib) to treat pediatric patients aged 12 and older with severe alopecia areata (AA). This approval is based on data from the BRAVE-AA-PEDS study, which demonstrated significant scalp hair regrowth and improvements in eyebrows and eyelashes. The approval expands Olumiant's use, which was previously established for adults with rheumatoid arthritis and severe AA. https://www.openbell.ai/news/GDHG:1790370556191 2026-09-25T21:09:16.191Z daily 0.9 https://cdn.brandfetch.io/GDHG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Golden Heaven Group's Nanping Golden Carnival Culture Development Co. Acquires Amusement Park Assets For RMB139.9 Million; 50% Of Purchase Price Due Within Five Business Days; Remaining 50% Upon Asset Delivery On September 25, 2026, Nanping Golden Carnival Culture Development Co., Ltd., a subsidiary of Golden Heaven Group Holdings Ltd., acquired amusement park assets from Guangxi Senguang Entertainment Investment Co., Ltd. for a total of RMB139.9 million. The purchase includes assets from Yixing Qinglongshan Happy World, Nanning Caribbean Water World, and Lishui Xingzhuang Park Children’s Amusement Park, with 50% of the payment due within five business days and the remaining 50% upon asset delivery. https://www.openbell.ai/news/TDIC:1790370352282 2026-09-25T21:05:52.282Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Communication Services Stocks Moving In Friday's After-Market Session In Friday's after-market session, Dreamland (NASDAQ: TDIC) shares surged 16.1% to $3.67, with a market cap of $6.7 million. Other notable gainers included NFT (AMEX: MI), which rose 11.45% to $2.53, and Motorsport Games (NASDAQ: MSGM), up 4.44% to $4.47, with a market value of $19.2 million. Conversely, Able View Global (NASDAQ: ABLV) saw a decline of 12.3% to $1.14, while Urban One (NASDAQ: UONEK) fell 10.19% to $3.35, with a market cap of $16.7 million. https://www.openbell.ai/news/ONCO:1790370351972 2026-09-25T21:05:51.972Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Health Care Stocks Moving In Friday's After-Market Session In Friday's after-market session, Onconetix (NASDAQ: ONCO) saw its stock rise by 10.3% to $1.14, with a market value of $3.9 million. Other notable gainers included Bullfrog AI Holdings (NASDAQ: BFRG), which increased by 10.29% to $0.73, and Adicet Bio (NASDAQ: ACET), up 9.82% to $9.91, with market caps of $14.1 million and $77.4 million respectively. Conversely, NewGenIvf Group (NASDAQ: NIVF) experienced a decline of 7.7% to $0.52, bringing its market cap to $1.3 million. https://www.openbell.ai/news/MIMI:1790370351754 2026-09-25T21:05:51.754Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Industrials Stocks Moving In Friday's After-Market Session In Friday's after-market session, Mint (NASDAQ:MIMI) shares rose 7.9% to $0.83, with a market value of $10.5 million. YYForce (NASDAQ:YFOR) shares increased by 6.8% to $1.57, while Armlogi Holding (NASDAQ:BTOC) saw a 6.76% rise to $0.28. Conversely, Galaxy Payroll Group (NASDAQ:GLXG) shares declined by 7.1% to $1.05, and Professional Diversity (NASDAQ:IPDN) stock decreased by 6.23% to $4.22. https://www.openbell.ai/news/MX:1790370351497 2026-09-25T21:05:51.497Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Information Technology Stocks Moving In Friday's After-Market Session In Friday's after-market session, MagnaChip Semiconductor (NYSE: MX) saw a significant increase of 15.8%, reaching a stock price of $3.82, with a market capitalization of $116.1 million. Other notable gainers included Schmid Group (NASDAQ: SHMD) up 8.92% to $4.76, and UTime (NASDAQ: FXHO) rising 6.37% to $10.6. Conversely, WidePoint (AMEX: WYY) experienced a decline of 7.0%, dropping to $5.09, while Innoviz Technologies (NASDAQ: INVZ) fell 6.5% to $0.36. https://www.openbell.ai/news/CLDI:1790370201368 2026-09-25T21:03:21.368Z daily 0.9 https://cdn.brandfetch.io/CLDI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Calidi Biotherapeutics Receives NYSE American Non-Compliance Notice Calidi Biotherapeutics, Inc. (NYSE: CLDI) received a non-compliance notice from NYSE American on September 21, 2026, due to insufficient stockholders' equity, which must be at least $4 million. The company is required to submit a compliance plan by October 21, 2026, to regain compliance by March 21, 2028, or face potential delisting. The notice does not immediately affect the trading of its common stock, which will continue to trade under the symbol 'CLDI' with a '.BC' designation for being below compliance. Management is currently reviewing options to address the deficiencies. https://www.openbell.ai/news/NCPL:1790370171002 2026-09-25T21:02:51.002Z daily 0.9 https://cdn.brandfetch.io/NCPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Netcapital Receives Additional Nasdaq Non-Compliance Notice Due To Delinquent Q1 Form 10-Q And Fiscal 2026 Form 10-K Filings Netcapital Inc. (NASDAQ: NCPL) received a notice from Nasdaq on September 21, 2026, for failing to file its Quarterly Report on Form 10-Q for the quarter ending July 31, 2026, and its Annual Report on Form 10-K for the fiscal year ending April 30, 2026, violating Nasdaq Listing Rule 5250(c)(1). The company has until October 23, 2026, to submit a compliance plan, which, if accepted, could grant an extension until February 9, 2027, to regain compliance. The notice does not currently affect the trading of NCPL stock, which continues to be listed on Nasdaq. https://www.openbell.ai/news/FMAC:1790370143045 2026-09-25T21:02:23.045Z daily 0.9 https://cdn.brandfetch.io/FMAC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Future Money Acquisition Corp. Receives Nasdaq Deficiency Notice Over Delayed July 31, 2026 Quarterly Form 10-Q Filing Future Money Acquisition Corporation (NASDAQ: FMAC) received a deficiency notice from Nasdaq on September 22, 2026, due to its failure to file the Quarterly Report on Form 10-Q for the fiscal quarter ending July 31, 2026. The company has 60 days to submit a compliance plan, with the possibility of an extension of up to 180 days if accepted. Future Money Acquisition is actively working to file the report and regain compliance, but there is no guarantee of success within the required timeframe. https://www.openbell.ai/news/BSX:1790370100497 2026-09-25T21:01:40.497Z daily 0.9 https://cdn.brandfetch.io/BSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Classifies Boston Scientific's Recall Of Imager II Angiographic Catheters As Class I Due To Potential Catheter Tip Degradation And Detachment Risk The FDA has classified Boston Scientific's recall of Imager II angiographic catheters as a Class I recall due to risks associated with potential catheter tip degradation and detachment. This classification indicates that the issue poses a significant risk of serious injury or death. The recall affects the safety and efficacy of the devices, which may impact the company's reputation and sales in the medical device market. https://www.openbell.ai/news/HIG:1790368947650 2026-09-25T20:42:27.650Z daily 0.9 https://cdn.brandfetch.io/HIG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hartford Insurance Group Inks Reinsurance Commutation And Release Agreement With National Indemnity Company To Commute And Terminate Aggregate Excess Of Loss Reinsurance Agreement; Commutation Agreement Resolves Confidential Arbitration Dispute Under Reinsurance Agreement; Hartford Fire Insurance Receives $1.12B Cash Payment On September 25, 2026, Hartford Fire Insurance Company received a cash payment of $1.12 billion from National Indemnity Company as part of a Reinsurance Commutation and Release Agreement, which terminated their existing Aggregate Excess of Loss Reinsurance Agreement. This agreement resolves a confidential arbitration dispute related to the reinsurance agreement that had been in place since December 31, 2016. Following this payment, both parties were released from liabilities and obligations under the agreement. https://www.openbell.ai/news/MVBF:1790368443801 2026-09-25T20:34:03.801Z daily 0.9 https://cdn.brandfetch.io/MVBF/w/400/h/400?c=1idopYfmtR7ZKg8QMud DingoBlu Financial Announces Strategic Partnership With MVB Bank To Develop Mobile-First Financial Platform And Visa Debit Card Program DingoBlu Financial, Inc. has announced a strategic partnership with MVB Bank, Inc. to develop a mobile-first financial platform and a Visa debit card program. This collaboration will leverage MVB Bank's regulated banking infrastructure to support DingoBlu's deposit products and banking services. DingoBlu aims to provide a streamlined mobile experience for managing everyday finances, with offerings including checking and savings accounts, digital account-management tools, and Visa debit card access. https://www.openbell.ai/news/MRK:1790368421974 2026-09-25T20:33:41.974Z daily 0.9 https://cdn.brandfetch.io/MRK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Merck, Daiichi Sankyo Voluntarily Withdraw Biologics License Application Approval In U.S. For Ifinatamab Deruxtecan To Treat Small Cell Lung Cancer After Discussions With FDA Merck and Daiichi Sankyo have voluntarily withdrawn their Biologics License Application (BLA) for ifinatamab deruxtecan (I-DXd) aimed at treating extensive-stage small cell lung cancer in the U.S. This decision follows discussions with the FDA, indicating that the data from the IDeate-Lung01 phase 2 trial did not meet the necessary requirements for accelerated approval. The accelerated approval pathway is designed for serious conditions with unmet medical needs. https://www.openbell.ai/news/HIG:1790368214932 2026-09-25T20:30:14.932Z daily 0.9 https://cdn.brandfetch.io/HIG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hartford Insurance Group Inks Reinsurance Commutation And Release Agreement With National Indemnity Company To Commute And Terminate Aggregate Excess Of Loss Reinsurance Agreement; Commutation Agreement Resolves Confidential Arbitration Dispute Under Reinsurance Agreement; Hartford Fire Insurance Receives $1.12B Cash Payment Hartford Insurance Group has entered into a reinsurance commutation and release agreement with National Indemnity Company, which will terminate their aggregate excess of loss reinsurance agreement. This agreement resolves a confidential arbitration dispute related to the reinsurance agreement. As part of the settlement, Hartford Fire Insurance will receive a cash payment of $1.12 billion. https://www.openbell.ai/news/HIG:1790368168343 2026-09-25T20:29:28.343Z daily 0.9 https://cdn.brandfetch.io/HIG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hartford Insurance Group Inks Reinsurance Commutation And Release Agreement With National Indemnity Company To Commute And Terminate Aggregate Excess Of Loss Reinsurance Agreement; Commutation Agreement Resolves Confidential Arbitration Dispute Under Reinsurance Agreement; Hartford Fire Insurance Receives $1.12B Cash Payment openbell Financial News https://www.openbell.ai/news/ACET:1790367745819 2026-09-25T20:22:25.819Z daily 0.9 https://cdn.brandfetch.io/ACET/w/400/h/400?c=1idopYfmtR7ZKg8QMud Adicet Bio shares are trading higher after the company announced it will report clinical data from the Phase 1 study evaluating prulacabtagene leucel as a potential treatment for patients with systemic lupus erythematosus with or without lupus nephritis. openbell Financial News https://www.openbell.ai/news/NTR:1790366878647 2026-09-25T20:07:58.647Z daily 0.9 https://cdn.brandfetch.io/NTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Canpotex Invests C$500M In Neptune Bulk Terminals At Port Of Vancouver; Project To Support 400-500 Jobs With Majority Spending To Canadian Suppliers Canpotex has announced a C$500 million investment in Neptune Bulk Terminals located at the Port of Vancouver. This project is expected to create between 400 to 500 jobs and will primarily source spending from Canadian suppliers. The investment underscores Canpotex's commitment to enhancing its operational capabilities in the region. https://www.openbell.ai/news/AMD:1790366525409 2026-09-25T20:02:05.409Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Shanghai-china-nov-22nd-2025-Amd-Company.jpg?width=250&height=187 AMD Hits $1 Trillion, Muse Spooks Subscription Stocks: This Week on Wall Street Advanced Micro Devices Inc. (AMD) achieved a market capitalization of over $1 trillion for the first time, with shares rising as much as 10% during the week, marking a nearly tripling in stock value since the beginning of the year. This surge was driven by increased demand for AI chips, widening the performance gap with Nvidia Corp. to over 160 percentage points. Meanwhile, the broader market faced challenges as Treasury yields spiked, with the 10-year yield reaching 5.2%, the highest since 2007. https://www.openbell.ai/news/ACET:1790366497900 2026-09-25T20:01:37.900Z daily 0.9 https://cdn.brandfetch.io/ACET/w/400/h/400?c=1idopYfmtR7ZKg8QMud Adicet Bio To Report Clinical Data From Phase 1 Study Evaluating Prulacabtagene Leucel As Potential Treatment For Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis On September 28 Adicet Bio, Inc. (NASDAQ: ACET) will report clinical data from its Phase 1 study on prulacabtagene leucel (prula-cel) as a potential treatment for systemic lupus erythematosus, including cases with or without lupus nephritis, on September 28, 2026. The company will also host a webcast presentation at 8:00am ET to discuss the results following the announcement. https://www.openbell.ai/news/HUBC:1790366459258 2026-09-25T20:00:59.258Z daily 0.9 https://cdn.brandfetch.io/HUBC/w/400/h/400?c=1idopYfmtR7ZKg8QMud HUB Cyber Security Receives Nasdaq Noncompliance Notice openbell Financial News https://www.openbell.ai/news/DAL:1790365717272 2026-09-25T19:48:37.272Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Delta-Air-Lines-Jet-Overturns-At-Toronto.jpg?width=250&height=187 Delta Air Lines Stock Rises Friday: What's Going On? Delta Air Lines Inc. (NYSE: DAL) shares rose 2.78% to $85.06 on Friday, driven by a broader rally in the aviation sector following a diplomatic breakthrough in the Middle East that led to a decline in global crude oil and jet fuel prices. The easing of geopolitical risks has reduced energy costs, which are significant for airlines, enhancing profitability expectations as the fourth-quarter holiday travel season approaches. This favorable energy landscape may alleviate investor concerns regarding domestic capacity oversupply and margin compression. https://www.openbell.ai/news/TT:1790365640706 2026-09-25T19:47:20.706Z daily 0.9 https://cdn.brandfetch.io/TT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trane Technologies shares are trading higher after Wells Fargo initiated coverage on the stock with an Overweight rating and announced a $536 price target. openbell Financial News https://www.openbell.ai/news/TSLA:1790365381208 2026-09-25T19:43:01.208Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Tesla-Optimus-Futuristic-Humanoid-Autono.jpg?width=250&height=187 Exclusive: Tesla Optimus Commercialization Next Year Is ‘Very Realistic,’ Faraday Chairman Says Faraday Future's Global Executive Chairman Jerry Wang stated that Tesla could realistically commercialize its Optimus humanoid robot by 2027, with software and training being the primary challenges. Faraday has already delivered over 500 robots this year and anticipates that humanoid robots could become common purchases for businesses and households within three to five years, potentially costing less than $20,000. Wang emphasized the importance of real-world data for robot training, indicating that the hardware is advanced but software development lags significantly. https://www.openbell.ai/news/EQPT:1790365347616 2026-09-25T19:42:27.616Z daily 0.9 https://cdn.brandfetch.io/EQPT/w/400/h/400?c=1idopYfmtR7ZKg8QMud EquipmentShare.com Refutes Recent Blue Orca Capital Report EquipmentShare.com Inc (Nasdaq: EQPT) has issued a statement refuting a report by Blue Orca Capital, which it claims mischaracterizes its business model and financial statements. The company emphasizes that it adheres to U.S. GAAP and SEC disclosure requirements, with its financials audited by a Big 4 firm. EquipmentShare asserts that its operational performance and growth strategy remain strong, aiming to expand its presence in the construction technology and rental markets. https://www.openbell.ai/news/AAL:1790364972007 2026-09-25T19:36:12.007Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Phoenix--Az---December-7--2019-Photo-Of-.jpg?width=250&height=187 American Airlines Stock Climbs Friday: What's Happening? American Airlines Group Inc. (NASDAQ: AAL) shares rose 3.52% to $13.82 on Friday, driven by a de-escalation in Middle East geopolitical tensions that led to a decline in global crude oil and jet fuel prices. The announcement from Iran regarding a plan to reopen the Strait of Hormuz has alleviated geopolitical risks, benefiting the airline industry by reducing fuel costs, which are a significant operating expense. This decrease in jet fuel prices is expected to improve American Airlines' margin expectations as it approaches the busy fourth-quarter holiday travel season. https://www.openbell.ai/news/BTCUSD:1790364631830 2026-09-25T19:30:31.830Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Bitcoin-Btc-Cryptocurrency-Coin-With-Alt.jpg?width=250&height=187 Bitcoin Slips Below $84,000 as Ethereum Holds $2,600, XRP and Dogecoin Rise on Rate-Hike Fears Bitcoin (BTC) has fallen to $83,783.63, slipping below the $84,000 mark amid concerns over interest-rate hikes. Ethereum (ETH) is holding at $2,686.78, while XRP and Dogecoin have seen increases. In the past 24 hours, 79,553 traders were liquidated, totaling $278.63 million, and there were net inflows of $190.7 million into spot Bitcoin ETFs and $66.01 million into spot Ethereum ETFs. https://www.openbell.ai/news/PLTR:1790364532196 2026-09-25T19:28:52.196Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Peter-Thiel-Says-Popes-AI-Push-Could-Ben.jpg?width=250&height=187 Peter Thiel: Palantir Sales to US Corporations Accelerated 'Tremendously' As Europe Falls Behind in AI Palantir Technologies Inc. reported a 55% year-over-year increase in U.S. commercial revenue, reaching $159 million in Q2 2024, with a notable 83% rise in U.S. commercial customer count. Co-founder Peter Thiel highlighted the acceleration of sales to U.S. corporations as they adapt to artificial intelligence, contrasting this with Europe's slower adoption. Thiel emphasized the need for Europe to enhance its economy and compete in AI, as recent IMF data indicates a significant lag in AI adoption compared to the U.S. https://www.openbell.ai/news/PLTR:1790364492885 2026-09-25T19:28:12.885Z daily 0.9 https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Peter Thiel: Palantir Sales to US Corporations Accelerated 'Tremendously' As Europe Falls Behind in AI Palantir Technologies Inc. reported a 55% year-over-year increase in U.S. commercial revenue, reaching $159 million in Q2 2024, with a notable 83% rise in total U.S. commercial customer count. Co-founder Peter Thiel emphasized that U.S. companies are rapidly adopting AI, contrasting this with Europe's slower pace, which he described as 'extremely far behind.' Thiel's remarks align with recent IMF warnings about Europe's lag in AI adoption compared to the U.S. https://www.openbell.ai/news/DOW:1790364429984 2026-09-25T19:27:09.984Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Dow-Chemical.jpg?width=250&height=187 Dow Stock Drops Following UBS Price Target Cut Dow Inc. (NYSE: DOW) shares fell 2.66% to $27.80 following a price target reduction by UBS analyst Joshua Spector, who lowered the 12-month target from $32 to $30 while maintaining a Neutral rating. This adjustment reflects ongoing margin pressures in the global commodity chemicals sector, driven by slow industrial demand recovery and elevated raw material costs. The chemicals sector is particularly affected by weak industrial activity in Europe and insufficient economic stimulus from China, impacting pricing power and EBITDA estimates. https://www.openbell.ai/news/QCOM:1790364400607 2026-09-25T19:26:40.607Z daily 0.9 https://cdn.brandfetch.io/QCOM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of semiconductor companies are trading higher after the Anthropic-Akamai deal demonstrated industry demand. Also, Meta's Muse AI agent strengthens the case for continued spending on CPUs, GPUs and AI infrastructure. openbell Financial News https://www.openbell.ai/news/BCBP:1790363695035 2026-09-25T19:14:55.035Z daily 0.9 https://cdn.brandfetch.io/BCBP/w/400/h/400?c=1idopYfmtR7ZKg8QMud BCB Bancorp Subsidiary BCB Community Bank Agrees tO Sell $205.3M In Problem Loans BCB Bancorp's subsidiary, BCB Community Bank, has agreed to sell several portfolios of problem loans totaling approximately $205.3 million, with an estimated pre-tax loss of $43.3 million expected to be recorded in Q3 2026. The loan portfolios include commercial and multifamily real estate loans, commercial and industrial loans, and construction loans. Closing has been completed for five of the six transactions, with the final one anticipated to close by the end of Q3 2026. Hilltop Securities Inc. acted as financial advisor for the transactions. https://www.openbell.ai/news/TSEM:1790363536232 2026-09-25T19:12:16.232Z daily 0.9 https://cdn.brandfetch.io/TSEM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tower Semiconductor shares are trading higher after Mizuho initiated coverage on the stock with an Outperform rating and announced a $300 price target. openbell Financial News https://www.openbell.ai/news/NGG:1790363320329 2026-09-25T19:08:40.329Z daily 0.9 https://cdn.brandfetch.io/NGG/w/400/h/400?c=1idopYfmtR7ZKg8QMud National Grid Selected For DOE Funding To Deploy Advanced Technology Across New England Transmission Network National Grid has been selected for funding from the Department of Energy (DOE) to implement advanced technology across its transmission network in New England. This initiative aims to enhance the efficiency and reliability of electricity delivery in the region. The financial details of the funding have not been disclosed, but the project is expected to have a significant impact on the company's operations and the local energy market. https://www.openbell.ai/news/REBN:1790363218774 2026-09-25T19:06:58.774Z daily 0.9 https://cdn.brandfetch.io/REBN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Reborn Coffee Stock Gaining Friday? Reborn Coffee Inc. (NASDAQ: REBN) stock rose 9.73% to $1.24 after the company signed a strategic memorandum of understanding with Visvita to enhance its global franchise supply chain. The partnership aims to leverage Visvita's established beverage supplier network and logistics to support franchise expansion and launch a co-branded ready-to-drink beverage line. Although the memorandum is nonbinding and definitive agreements are yet to be negotiated, the collaboration is expected to facilitate store growth in North America and Latin America. Reborn Coffee has a market capitalization of nearly $10 million and operates 10 retail locations. https://www.openbell.ai/news/INCY:1790362552268 2026-09-25T18:55:52.268Z daily 0.9 https://cdn.brandfetch.io/INCY/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Approves Atebrioz (Zilurgisertib) For Fibrodysplasia Ossificans Progressiva In Adults & Pediatric Patients 12+ Years; Atebrioz Recommended Dosage 100mg Once Daily The FDA has approved Atebrioz (Zilurgisertib) for the treatment of Fibrodysplasia Ossificans Progressiva in adults and pediatric patients aged 12 years and older. The recommended dosage for Atebrioz is 100mg once daily. This marks a significant advancement in treatment options for this rare condition, potentially impacting the stock performance of Incyte Corporation (ticker: INCY). https://www.openbell.ai/news/REBN:1790362513842 2026-09-25T18:55:13.842Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/25/Investors-Analyze-The-Data-Stock-Market-.jpg?width=250&height=187 Why Is Reborn Coffee Stock Gaining Friday? Reborn Coffee Inc. (NASDAQ: REBN) stock rose 9.73% to $1.24 following the announcement of a strategic memorandum of understanding with Visvita to enhance its global franchise supply chain. The partnership aims to leverage Visvita's established beverage supplier network and logistics to support Reborn Coffee's franchise expansion and the launch of a co-branded ready-to-drink beverage line. Currently, Reborn Coffee has a market capitalization of nearly $10 million and operates 10 retail locations, with a 50.20% decline in stock value over the past year.